Real-world evidence on efmoroctocog alfa in patients with haemophilia A: A systematic literature review of treatment experience in Europe.
Jan BlatnýEmma Munk NielsenSigne Baattrup ReitzelAnnabell Cajus McMillanAnne DanøLinda BystrickáNana KraghRobert KlamrothPublished in: Haemophilia : the official journal of the World Federation of Hemophilia (2023)
rFVIIIFc prophylaxis treatment results in a low ABR across studies in patients with haemophilia A in a European real-world setting, which correlates with findings from clinical trials assessing the efficacy of rFVIIIFc in patients with haemophilia A.
Keyphrases